Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Heart surgeons may deliver better outcomes during stressful procedures
Excessive stress may still be harmful to a surgeon's performance, researchers warned, but moderate stress early on during a procedure appears to reduce the odds of a major complication.
Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR
RBBB remains the single strongest predictor for PPMI after TAVR, but high AV calcium scores still provide care teams with considerable value.
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."

Amid COVID-19 vaccine rollout, providers may slowly resume ventilation/perfusion lung scans

SNMMI said V/Q scans can be increasingly incorporated as a normal part of the workup of suspected pulmonary embolism.

Patients with pulmonary arterial hypertension benefit from sotatercept treatment

After 24 weeks, treatment with sotatercept was associated with a significant reduction in pulmonary vascular resistance.

Beta-blockers raise the risk of heart disease, stroke among people with HIV

The study, published in Hypertension, included data from more than 8,000 U.S. veterans.

CT data shows high rates of emphysema among marijuana users

Radiologists should take note of these findings as the drug's popularity and legalization continue to climb.

What TAVR availability has meant for patients with severe aortic stenosis

The impact on patients over the age of 65 has been undeniable.

FDA approves alirocumab for treating homozygous familial hypercholesterolemia

The medication, a PCSK9 inhibitor, was already an approved therapy for adult patients with cardiovascular disease.

Excess deaths in the US jumped 23% in 2020—COVID-19, heart disease and diabetes all played key roles

The study's authors warned that excess deaths may continue to rise if states don't learn any lessons from the last year.

Dapagliflozin provides significant benefits for both male and female heart failure patients

The findings, published in JAMA Cardiology, confirm that dapagliflozin is a safe, effective treatment option for patients with heart failure with reduced ejection fraction.

Clinical

Heart surgeons may deliver better outcomes during stressful procedures

Aortic valve calcium scores help predict need for a permanent pacemaker after TAVR

Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

Congressional candidate physician sues hospital and doctor for death of father

Diabetes reduces survival after SAVR, but not TAVR